Aptevo Therapeutics Inc. - Common Stock (APVO)

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

APVO shares rose 46.10% to $2.06 after promising clinical results, but the stock has dropped 98.84% over the past year.

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

The company stated that the 100% remission rate achieved at the highest dose level of the trial demonstrated the drug’s potential to redefine the frontline treatment landscape for newly diagnosed AML patients who are unfit for intensive chemotherapy.

Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.